Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function

Inclusion Criteria:

• Subjects with normal hepatic function and liver parameters within normal range
• Subjects with stable hepatic impairment classified as Child-Pugh grade A, B or C
• Body Mass Index between 18.5-40.0 kg/m^2 (both inclusive)

Exclusion Criteria:

• Known or suspected allergy to trial product or related products
• Liver transplanted subjects
• Cardiac problems
• Uncontrolled treated/untreated hypertension
• Signs of acute liver insufficiency
• Positive HIV (human immunodeficiency virus) 1+2 antibodies
• Cancer or any clinically significant disease or disorder except for conditions associated with the hepatic impairment
• Impaired renal function
• Smoking of more than 10 cigarettes per day, or the equivalent for other tobacco products
• Habitual excessive consumption of methylxanthine-containing beverages and foods (coffee, tea, soft drinks such as cola, chocolate) as judged by the investigator